Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
The two compounds engage distinct but complementary research pathways BPC-157 is primarily investigated for angiogenesis, fibroblast migration, and nitric oxide modulation, while TB-500 is studied for G-actin sequestering activity and cytoskeletal reorganization in cell migration
People who were taking them tended to lose a little bit of weight and so the drug companies that manufactured them wondered if people taking larger doses would lose more weight (at least short term.) They did, and then applied for and received FDA approval here in the US specifically for weight loss
With obesity rates climbing scientists predict that by 2050, four in five Americans will be obese or overweight demand for effective treatments will only grow
